MIRA INFORM REPORT

 

 

Report No. :

322770

Report Date :

26.05.2015

 

IDENTIFICATION DETAILS

 

Name :

GENFAR SA

 

 

Registered Office :

Calle 20A 44-70 Bogota

 

 

Country :

Colombia

 

 

Financials (as on) :

2013

 

 

Date of Incorporation :

01.04.1998

 

 

Legal Form :

Sociedad Anonima

 

 

Line of Business :

The company engages in the development and marketing of pharmaceuticals for

human and veterinary use.

 

 

No. of Employees :

935

 

 

RATING & COMMENTS

 

MIRA’s Rating :

B

 

RATING

STATUS

PROPOSED CREDIT LINE

26-40

B

Capability to overcome financial difficulties seems comparatively below average.

Small

 

Status :

Moderate

 

 

Payment Behaviour :

Unknown

 

 

Litigation :

Clear

 

 

NOTES:

Any query related to this report can be made on e-mail: infodept@mirainform.com while quoting report number, name and date.

 

 

ECGC Country Risk Classification List – December 31, 2014

 

Country Name

Previous Rating

(30.09.2014)

Current Rating

(31.12.2014)

Colombia

B2

B2

 

Risk Category

ECGC Classification

Insignificant

 

A1

Low

 

A2

Moderate

 

B1

High

 

B2

Very High

 

C1

Restricted

 

C2

Off-credit

 

D

 

 

 

COLOMBIA - ECONOMIC OVERVIEW

 

Colombia's consistently sound economic policies and aggressive promotion of free trade agreements in recent years have bolstered its ability to weather external shocks. Real GDP has grown more than 4% per year for the past four years, continuing almost a decade of strong economic performance. All three major ratings agencies have upgraded Colombia's government debt to investment grade, which helped to attract record levels of investment in 2013 and 2014, mostly in the hydrocarbons sector. Colombia depends heavily on energy and mining exports, making it vulnerable to a drop in commodity prices. Colombia is the world's fourth largest coal exporter and Latin America's fourth largest oil producer. Economic development is stymied by inadequate infrastructure, inequality, poverty, narco-trafficking and an uncertain security situation. Moreover, the unemployment rate of 9.2% in 2014 is still one of Latin America's highest. The SANTOS Administration's foreign policy has focused on bolstering Colombia's commercial ties and boosting investment at home. Colombia has signed or is negotiating Free Trade Agreements (FTA) with more than a dozen countries; the US-Colombia FTA went into force on May 2012. Colombia is also a founding member of the Pacific Alliance - a regional grouping formed in 2012 by Chile, Colombia, Mexico, and Peru to promote regional trade and economic integration. In 2013, Colombia began its ascension process to the OECD. In 2014, Colombia passed a tax reform bill to offset the lost revenue from the global drop in oil prices. The SANTOS administration is also using tax reform to help finance implementation of a peace deal, in the event FARC and the government reach an agreement in 2015. Colombian officials estimate a peace deal may bolster economic growth by almost 2%.

 

 

Source : CIA

 

REGISTERED NAME & COMPANY SUMMARY

 

IDENTIFICATION

Ordered as:

GENFAR SA

Address in the order:

NIT 817.001.644-1, Transversal 23 # 97-73 Piso 9 Edificio City

Postcode 0

Comments on data supplied:

Be advised the address in the order corresponds to the now parent company Sanofi-aventis S.A. The actual headquarters of the company is the one listed below. That is why we proceed on making the report under that information.

Legal Name:

GENFAR SA

Trade Name:

Laboratorios Genfar

Legal Address

Calle 20A 44-70 Bogota Colombia.

Postal Town

N.A.

Post Code

N.A.

Primary Geographic Area

Bogotá

Country

CO

Operative Address

Calle 20A 44-70 Bogota Colombia.

Telephone:

+571 - 368 79 58 / +571 368-0077

NIT :

817001644 -1  

Fax:

+571 - 335 34 79

Legal Form:

Sociedad Anonima

Email:

servicioalcliente@genfar.com

Registered in:

CO

Website:

www.genfar.com.co

Date Created:

1967

MANAGERS:

GARCIA BORRERO JUAN MANUEL, Manager.

Date Incorporated:

April 01st, 1998

Staff:

935

Stock:

N.A.

 

 

Value:

N.A.

Activity:

Development and marketing of pharmaceuticals.

 

 

DIRECTORS/MANAGEMENT

 

Management:

 

NICOLAS ENRIQUE MACCHIAVELLO, legal representative

JESUS HERNANDO CUBIDES BALLESTEROS, alternate legal representative

BOTERO CAICEDO MAURICIO, 2nd alternate legal representative

ADRIANA MARCELA CLAROS BAUTISTA, tax auditor

MARIELA GOMEZ GIRALDO, alternate tax auditor

GEOVANNI CASTILLO MORENO, accountant

Rosy Londońo, assistant

 

 

NEGATIVE INFORMATION

 

Legal Filings

 The sources consulted record no detrimental legal or labor court information.

SHARE & SHARE CAPITAL INFORMATION

 

Shareholders - RELATED COMPANIES

Listed at the stock exchange:

 

NO

Shareholders Parent Company(ies):

 

This is a private company and it was recently aquired by the Sanofi Group. The controlling company in the country is:

 

Sanofi-aventis S.A..

Transversal 23 No. 97 -73 Piso 9 Santiago de Cali Cauca Colombia.

Tel: +57-1-6214400

Fax: +57-1-7444232

 

This information was kindly provided by the company.

 

 

PAYMENT INFORMATION

 

Suppliers:

 

Granules India Ltd.

Registered office address:

2nd Floor, 3rd Block

My Home Hub

Madhapur,

Hyderabad- 500 081 (TG)

CIN: L24110TG1991PLC012471

 

 

Clients:

 

The company serves to the helath care and veterinary industry.

 

The company imports from India, Mexico

The company exports to Latin America

Trade References:

 

Despite of our searches it has not been possible to identify the company's suppliers for us to get credit references.

 

 

DEBT COLLECTIONS AND PAYMENTS

Public

NO

Payments

REGULAR

 

 

GROUP STRUCTURE & AFFILIATED COMPANIES

 

RELATED COMPANIES:

The subject is also affiliated to:

 

Chuao Caracas Venezuela

VENEZUELA

División Humanos y Salud Animal

 

ECUADOR:

Guayaquil

GENFAR ECUADOR

División Humana y Salud Animal

 

MEXICO:

Ciudad de México

Laboratorios HEXAL S.A, de C.V.

 

GUATEMALA:

 

Ciudad de Guatemala

BOFASA

 

Ciudad de Guatemala

GENFARVET GUATEMALA

Salud Animal

 

HONDURAS:

 

San Pedro Sula

SERVICIOS TÉCNICOS Y COMERCIALES

Salud Animal

Residencial Real del Puente 2da. Etapa, Bloque E, casa 34B

 

NICARAGUA:

COSERVISA S.A.

 

COSTA RICA:

VETIM S.A.

 

However, we were unable to identify the exact relation by the time we called.

 

 

FINANCIAL INFORMATION

 

FINANCIALS - COMMERCIAL TRENDS AND FORECAST

This is a privately held business.

 

For a better approach we have transcribed the main figures in the chart below.

 

We have contacted Rosy Londońo, assistant who explained us they are not authorized to provide any information about the company without previous authorization of its parent company.

Currency

DATE

COP

2013

Turnover

281 291 079 000

Operating Income

76 385 210 000

Net Income

9 888 900 000

Current Assets

166 929 250 000

Non-Current Assets

153 137 523 000

Net worth

129 597 833 000

Bank liabilities

190 468 940 000

The cash flow is

Normal

 

Comments on the financial data: Please find enclosed the figures published by the company from 2010 to 2013.

No recent financial data was provided or released for 2014.

 

FINANCIAL SUMMARY

 

Profitability

CORRECT

Indebtedness

CONTROLLED

Cash

NORMAL

 

 

GENFAR S.A. - Financial Statements 2013 (In thousands of COP)

 

 

 

 

 

 

 

 

NIT

RAZON SOCIAL

MACROSECTOR

SECTOR

CIIU v 3

DEPARTAMENTO

41 INGRESOS OPERACIONALES / REVENUE

817001644

GENFAR S.A.

MANUFACTURERO

PRODUCTOS QUIMICOS

D2423

CAUCA

281,291,079

 

 

 

 

 

 

 

NIT

RAZON SOCIAL

MACROSECTOR

SECTOR

CIIU v 3

DEPARTAMENTO

CIUDAD

817001644

GENFAR S.A.

MANUFACTURERO

PRODUCTOS QUIMICOS

D2423

CAUCA

#NAME?

 

 

61 MENOS COSTO DE VENTAS Y DE PRESTACION DE SERVICIOS

UTILIDAD BRUTA

51 MENOS GASTOS OPERACIONALES DE ADMINISTRACION

52 MENOS GASTOS OPERACIONALES DE VENTAS

UTILIDAD OPERACIONAL / OPERATING INCOME

42 MAS INGRESOS NO OPERACIONALES

53 MENOS GASTOS NO OPERACIONALES

129,905,709

151,385,370

15,126,081

59,874,079

76,385,210

12,869,074

68,868,030

 

 

 

 

 

 

 

1105 CAJA

1110 BANCOS

1115 REMESAS EN TRANSITO

1120 CUENTAS DE AHORRO

1125 FONDOS

11 SUBTOTAL DISPONIBLE

12 INVERSIONES

13,097

2,777,388

 

767,550

21,689

3,579,724

1,094,707

 

 

UTILIDAD ANTES DE IMPUESTOS

54 MENOS IMPUESTO DE RENTA Y COMPLEMENTARIOS

59 GANANCIAS Y PERDIDAS / NET INCOME

 

 

 

20,386,254

10,497,354

9,888,900

 

 

 

 

 

 

 

 

 

1305 CLIENTES

1310 CUENTAS CORRIENTES COMERCIALES CP

1315 CUENTAS POR COBRAR A CASA MATRIZ CP

1320 CUENTAS POR COBRAR A VINCULADOS ECONOMICOS CP

1323 CUENTAS POR COBRAR A DIRECTORES CP

1325 CUENTAS POR COBRAR A SOCIOS Y ACCIONISTAS CP

101,922,042

445,694

0

0

0

0

 

 

1328 APORTES POR COBRAR CP

1330 ANTICIPOS Y AVANCES CP

1332 CUENTAS DE OPERACION CONJUNTA CP

1335 DEPOSITOS CP

1340 PROMESAS DE COMPRAVENTA CP

1345 INGRESOS POR COBRAR CP

1350 RETENCION SOBRE CONTRATOS CP

0

60,664

0

12,962

0

26,053

0

 

 

1355 ANTICIPO DE IMPTOS Y CONTRIB O SALDOS A FAVOR CP

1360 RECLAMACIONES CP

1365 CUENTAS POR COBRAR A TRABAJADORES CP

1370 PRESTAMOS A PARTICULARES CP

1380 DEUDORES VARIOS CP

1385 DERECHOS DE RECOMP DE CART NEGOCIADA CP

1390 DEUDAS DE DIFICIL COBRO CP

1399 PROVISIONES CP

1,525,430

33,841

1,400,230

0

169,822

0

0

6,547,378

 

13 SUBTOTAL DEUDORES CP

1405 MATERIAS PRIMAS

1410 PRODUCTOS EN PROCESO

1415 OBRAS DE CONSTRUEN CURSO

1417 OBRAS DE URBANISMO

1420 CONTRATOS EN EJECUCION CP

1425 CULTIVOS EN DESARROLLO CP

99,049,360

17,100,435

3,716,091

0

0

 

 

 

1428 PLANTACIONES AGRICOLAS CP

1430 PRODUCTOS TERMINADOS

1435 MERCANCIAS NO FABRICADAS POR LA EMPRESA

1440 BIENES RAICES PARA LA VENTA

1445 SEMOVIENTES CP

1450 TERRENOS

1455 MATERIALES REPUESTOS Y ACCESORIOS CP

1460 ENVASES Y EMPAQUES CP

 

22,501,078

1,570,620

0

 

0

2,184,619

7,534,263

 

1465 INVENTARIOS EN TRANSITO CP

1499 PROVISIONES CP

14 SUBTOTAL INVENTARIOS CP

1705 GASTOS PAGADOS POR ANTICIPADO CP

1710 CARGOS DIFERIDOS CP

1715 COSTOS DE EXPLORACION POR AMORTIZAR CP

1720 COSTOS DE EXPLOTACION Y DESARROLLO CP

9,858,567

1,390,558

63,075,115

130,344

 

 

 

 

1730 CARGOS POR CORRECCION MONETARIA DIFERIDA CP

1798 AMORTIZACION ACUMULADA CP

17 SUBTOTAL DIFERIDO CP

TOTAL ACTIVO CORRIENTE / TOTAL CURRENT ASSETS

12 INVERSIONES

1305 CLIENTES

 

 

130,344

166,929,250

4,567,508

5,886,150

 

 

 

 

 

 

 

 

 

 

1310 CUENTAS CORRIENTES COMERCIALES

1315 CUENTAS POR COBRAR A CASA MATRIZ

1320 CUENTAS POR COBRAR A VINCULADOS ECONOM

1323 CUENTAS POR COBRAR A DIRECTORES

1325 CUENTAS POR COBRAR A SOCIOS Y ACCIONISTAS

1330 ANTICIPOS Y AVANCES

1332 CUENTAS DE OPERACION CONJUNTA

1335 DEPOSITOS

1340 PROMESAS DE COMPRAVENTA

0

0

0

0

0

0

0

0

0

 

1345 INGRESOS POR COBRAR

1350 RETENCION SOBRE CONTRATOS

1355 ANTICIPO DE IMPTOS Y CONTRIB O SALDOS A FAVOR

1360 RECLAMACIONES

1365 CUENTAS POR COBRAR A TRABAJADORES

1370 PRESTAMOS A PARTICULARES

1380 DEUDORES VARIOS

1385 DERECHOS DE RECOMP DE CART NEGOCIADA

1390 DEUDAS DE DIFICIL COBRO

0

0

0

0

0

0

0

0

0

 

1399 PROVISIONES

13 SUBTOTAL DEUDORES A LARGO PLAZO

15 PROPIEDADES PLANTA Y EQUIPO

1605 CREDITO MERCANTIL

1610 MARCAS

1615 PATENTES

1620 CONCESIONES Y FRANQUICIAS

0

5,886,150

69,896,295

1,108,029

15,404,050

 

 

 

1625 DERECHOS

1630 KNOW HOW

1635 LICENCIAS

1698 AMORTIZACION ACUMULADA

1699 PROVISIONES

16 SUBTOTAL INTANGIBLES

1705 GASTOS PAGADOS POR ANTICIPADO

1710 CARGOS DIFERIDOS

600,000

 

9,020,254

20,817,253

 

5,315,080

 

11,376,816

 

1715 COSTOS DE EXPLORACION POR AMORTIZAR

1720 COSTOS DE EXPLOTACION Y DESARROLLO

1730 CARGOS POR CORRECCION MONETARIA DIFERIDA

1798 AMORTIZACION ACUMULADA

17 SUBTOTAL DIFERIDOS

1805 BIENES DE ARTE Y CULTURA

 

 

 

 

11,376,816

 

 

1895 DIVERSOS

1899 PROVISIONES

18 SUBTOTAL OTROS ACTIVOS

1905 DE INVERSIONES

1910 DE PROPIEDADES PLANTA Y EQUIPO

1995 DE OTROS ACTIVOS

19 SUBTOTAL VALORIZACIONES

 

 

0

1,935,744

54,159,930

 

56,095,674

 

TOTAL ACTIVO NO CORRIENTE / FIXED ASSETS

TOTAL ACTIVO

21 OBLIGACIONES FINANCIERAS CP

22 PROVEEDORES CP

2305 CUENTAS CORRIENTES COMERCIALES CP

2310 A CASA MATRIZ CP

2315 A COMPANNIAS VINCULADAS CP

153,137,523

320,066,773

52,016,253

45,409,388

 

 

54,583,289

 

2320 A CONTRATISTAS CP

2330 ORDENES DE COMPRA POR UTILIZAR CP

2335 COSTOS Y GASTOS POR PAGAR CP

2340 INSTALAMENTOS POR PAGAR CP

2345 ACREEDORES OFICIALES CP

2350 REGALIAS POR PAGAR CP

2355 DEUDAS CON ACCIONISTAS O SOCIOS CP

 

 

12,153,357

 

 

 

 

 

2357 DEUDAS CON DIRECTORES CP

2360 DIVIDENDOS O PARTICIPACIONES POR PAGAR CP

2365 RETENCION EN LA FUENTE CP

2367 IMPUESTO A LAS VENTAS RETENIDO CP

2368 IMPUESTO DE INDUSTRIA Y COMERCIO RETENIDO CP

2370 RETENCIONES Y APORTES DE NOMINA CP

2375 CUOTAS POR DEVOLVER

2380 ACREEDORES CP

 

0

794,453

97,632

58,774

733,283

 

501,993

 

 

 

 

 

 

 

 

 

23 SUBTOTAL CUENTAS POR PAGAR CP

24 IMPUESTOS GRAVAMENES Y TASAS CP

25 OBLIGACIONES LABORALES CP

2605 PARA COSTOS Y GASTOS CP

2610 PARA OBLIGACIONES LABORALES CP

2615 PARA OBLIGACIONES FISCALES CP

2620 PENSIONES DE JUBILACION CP

68,922,781

4,397,502

2,017,185

5,044,164

1,074,948

1,219,904

0

 

 

2625 PARA OBRAS DE URBANISMO CP

2630 PARA MANTENIMIENTO Y REPARACIONES CP

2635 PARA CONTINGENCIAS CP

2640 PARA OBLIGACIONES DE GARANTIAS CP

2695 PROVISIONES DIVERSAS CP

26 SUBTOTAL PASIVOS ESTIMAD Y PROVIS CP

27 DIFERIDOS CP

 

 

529,517

 

 

7,868,533

 

 

2805 ANTICIPOS Y AVANCES RECIBIDOS CP

2810 DEPOSITOS RECIBIDOS CP

2815 INGRESOS RECIBIDOS PARA TERCEROS CP

2820 CUENTAS DE OPERACION CONJUNTA CP

2825 RETENCIONES A TERCEROS SOBRE CONTRATOS

2830 EMBARGOS JUDICIALES CP

2835 ACREEDORES DEL SISTEMA CP

 

2840 CUENTAS EN PARTICIPACION CP

2895 DIVERSOS CP

28 SUBTOTAL OTROS PASIVOS CP

2905 BONOS EN CIRCULACION CP

2910 BONOS OBLIGATOR CONVERTIBLES EN ACCIONES CP

2915 PAPELES COMERCIALES CP

2920 BONOS PENSIONALES CP

 

 

0

 

 

 

0

 

 

 

 

 

 

 

 

2925 TITULOS PENSIONALES CP

29 SUBTOTAL BONOS Y PAPELES COMERCIA CP

TOTAL PASIVO CORRIENTE

21 OBLIGACIONES FINANCIERAS

22 PROVEEDORES LP

2305 CUENTAS CORRIENTES COMERCIALES

2310 A CASA MATRIZ

0

0

180,631,642

0

0

 

 

 

 

 

2315 A COMPANNIAS VINCULADAS

2320 A CONTRATISTAS

2335 COSTOS Y GASTOS POR PAGAR

2345 ACREEDORES OFICIALES

2350 REGALIAS POR PAGAR

2355 DEUDAS CON ACCIONISTAS O SOCIOS

2357 DEUDAS CON DIRECTORES

2360 DIVIDENDOS O PARTICIPACIONES POR PAGAR

 

 

 

 

 

 

 

 

 

2375 CUOTAS POR DEVOLVER

2380 ACREEDORES VARIOS

23 SUBTOTAL CUENTAS POR PAGAR

24 IMPUESTOS GRAVAMENES Y TASAS LP

25 OBLIGACIONES LABORALES

2605 PARA COSTOS Y GASTOS

2610 PARA OBLIGACIONES LABORALES

2615 PARA OBLIGACIONES FISCALES

 

 

0

 

 

 

 

 

 

2620 PENSIONES DE JUBILACION LP

2625 PARA OBRAS DE URBANISMO

2635 PARA CONTINGENCIAS

2640 PARA OBLIGACIONES DE GARANTIAS

2695 PROVISIONES DIVERSAS

26 SUBTOTAL PASIVOS ESTIMAD Y PROVIS

0

 

 

 

 

0

 

2705 INGRESOS RECIBIDOS POR ANTICIPADO

2710 ABONOS DIFERIDOS

2715 UTILIDAD DIFERIDA EN VENTAS A PLAZOS

2720 CREDITO POR CORRECCION MONETARIA DIFERIDA

2725 IMPUESTOS DIFERIDOS

27 SUBTOTAL DIFERIDOS

2805 AVANCES Y ANTICIPOS RECIBIDOS

2810 DEPOSITOS RECIBIDOS

 

 

 

 

9,837,298

9,837,298

 

 

 

2815 INGRESOS RECIBIDOS PARA TERCEROS

2820 CUENTAS DE OPERACION CONJUNTA

2825 RETENCIONES A TERCEROS SOBRE CONTRATOS

2835 ACREEDORES DEL SISTEMA LP

2840 CUENTAS EN PARTICIPACION

2895 DIVERSOS

28 SUBTOTAL OTROS PASIVOS

 

 

 

 

 

 

0

 

2905 BONOS EN CIRCULACION

2910 BONOS OBLIGATOR CONVERTIBLES EN ACCIONES

2915 PAPELES COMERCIALES

2920 BONOS PENSIONALES LP

2925 TITULOS PENSIONALES LP

29 SUBTOTAL BONOS Y PAPELES COMERCIA

TOTAL PASIVO NO CORRIENTE

 

 

 

0

0

0

9,837,298

 

TOTAL PASIVO / LIABILITIES

3105 CAPITAL SUSCRITO Y PAGADO

3115 APORTES SOCIALES

3120 CAPITAL ASIGNADO

3125 INVERSION SUPLEMENTARIA AL CAPITAL ASIGNADO

3130 CAPITAL DE PERSONAS NATURALES

3135 APORTES DEL ESTADO

190,468,940

8,418,090

 

 

 

 

 

 

3140 FONDO SOCIAL

31 SUBTOTAL CAPITAL SOCIAL

3205 PRIMA EN COLOACCUOTAS O PARTES DE INT SOCIAL

3210 DONACIONES

3215 CREDITO MERCANTIL

3220 KNOW HOW

3225 SUPERAVIT METODO DE PARTICIPACION

 

8,418,090

3,798,665

 

 

 

-89,158

 

32 SUBTOTAL SUPERAVIT DE CAPITAL

33 RESERVAS

34 REVALORIZACION DEL PATRIMONIO

35 DIVIDEN O PARTDECRET EN ACO CUOTAS

36 RESULTADOS DEL EJERCICIO

3705 UTILIDADES ACUMULADAS

3710 PERDIDAS ACUMULADAS

3,709,507

18,918,810

32,566,852

 

9,888,900

 

 

 

37 RESULTADOS DE EJERCICIOS ANTERIORES

38 SUPERAVIT POR VALORIZACIONES

TOTAL PATRIMONIO / NET WORTH

TOTAL PASIVO Y PATRIMONIO

81 DERECHOS CONTINGENTES

82 DEUDORAS FISCALES

0

56,095,674

129,597,833

320,066,773

 

66,521,617

 

83 DEUDORAS DE CONTROL

9 CUENTAS DE ORDEN ACREEDORAS POR CONTRA

91 RESPONSABILIDADES CONTINGENTES

92 ACREEDORAS FISCALES

93 ACREEDORAS DE CONTROL

8 CTAS DE ORDEN DEUDORAS POR CONTRA

24,032,672

0

 

 

 

90,554,289

 

 

 

 

 

 

 

 

 

 

FOREIGN EXCHANGE RATES

 

N/a

 

 

ADDITIONAL INFORMATION

 

GEOPOLITICS - COLOMBIA

POLITICAL DATA

ECONOMIC DATA

Form of Government: Republic


Economic Risk: Low

Currency: 00.00 COP = 0.0401229 USD

Branch Situation: Stable

 

BANKS

Name of the Bank

BANCOLOMBIA

Location                                  

Confidential

Comments

We could not verify this information with the company.

 

Name of the Bank

Banco BBVA

Location                                  

1310 MADRID ST MARSHALL MN 56258- 4099

Comments

We could not verify this information with the company.

 

Name of the Bank

BANCO POPULAR

Location                                  

Confidential

Comments

We could not verify this information with the company.

 

 

BUSINESS HISTORY

 

 

Genfar S.A. was founded on August 18, 1967 and it is based and incorporated in Colombia.

 

With a pharmaceutical complex considered one of the most complete and modern in Latin America because of the excellence in human talent and technology in all processes of production, general management in Bogota Colombia, Ecuador and Peru in subsidiaries and distributors throughout South and Central America

 

The company was acquired recently by the Sanofi Group in 2013.

 

PRINCIPAL ACTIVITY

 

The company engages in the development and marketing of pharmaceuticals for human and veterinary use.

 

Products/Services description:

 

The company offers the following prodducts, among others:

Acetaminofén

Calcio

Clotrimazol

Diclofenaco

Genfargrip

Ibuprofeno 

Isoconazol 

Ketoprofeno

Piroxicam 

Rubogel 

Terbinafina 

Vitamina c 

Yodopovidona

 

Sales are:

 

Wholesale

 

Operations area:

 

National, International

 

The subject employs 935 employee(s)

Comments on staff:

 

We could not verify this information with the company.

 

Branches:

Manufacturing plant: Kilometro 43 Via Panamericana

Unidad Fabril Genfar de Villa Rica

Parque Industrial Caucadesa Villa Rica Cauca

Cali Colombia.

 

Barranquilla

Regional Barranquilla

 

Carrera 54 # 72 - 142 Piso 9. Edificio Corpavi

Tel:(095) 358 5976 / 6965 / 7836 - FAX: Ext 109

Email: rbarranquilla@genfar.com

 

Bogotá D.C.

DIRECCION GENERAL

 

Calle 20 A # 44 - 70

Tel:(571) 368 0077 - 368 7958 Fax: (571) 368 3850/3346 - A.A. 30406

Email: servicioalcliente@genfar.com

 

Cali

Regional Cali

 

Km 43 Vía Panamericana Cali – Popayán

Tel:(572) – 683 2208 / 2552 - 331 5448 / 5328

FAX: (572) 330 5506

Email: rcali@genfar.com

 

Medellín

Regional Medellín

 

CALLE 43A 1 SUR 188 - OFICINAS 502 Y 503 - TORRE EMPRESARIAL BANCAFE - AVENIDA EL POBLADO

Tel:265 67 03- 265 85 92 - 265 17 98 - 265 55 74 - 265 51 58- PBX: 265 90 11 - FAX: 268 93 45 -

Email: rmedellin@genfar.com

 

Villa Rica (Cauca)

COMPLEJO FARMACÉUTICO MULTILATINO

 

Km 43 Vía Panamericana Cali – Popayán

Tel:(572) 390 5400 Fax: (572) 390 5401 - A.A. 4584

Email: servicioalcliente@genfar.com

 

 

RATING

 

Local credit bureau gave a GOOD credit rate.

The company is in Good Standing. This means that all local and federal taxes were paid on due date.

 

 

NOTES & COMMENTS

 

 Final Opinion

 

Genfar S.A. is a large sized Colombian company employing about 935 people.

 

This is a big size, privately-held company, which has 48 years of experience in the market.

 

During the course of this investigation there were no legal filings found against the company.

 

In regards to the figures published by a Colombian official source, the company´s profitability is correct but its indebtedness is high.

 

Therefore, we recommend a maximum credit line of USD 1 500 000.

 

A review within six to eight months is advised to check the company's evolution.

 

APPENDIX

Comments

 

We have contacted Rosy Londońo, assistant who explained us they are not authorized to provide any information about the company without previous authorization of its parent company.

 

 

FOREIGN EXCHANGE RATES

 

Currency

Unit

Indian Rupees

US Dollar

1

Rs.63.62

UK Pound

1

Rs.98.51

Euro

1

Rs.69.93

 

INFORMATION DETAILS

 

Analysis Done by :

RAS

 

 

Report Prepared by :

VNT

 

               

RATING EXPLANATIONS

 

RATING

STATUS

PROPOSED CREDIT LINE

 

>86

Aaa

Possesses an extremely sound financial base with the strongest capability for timely payment of interest and principal sums

 

Unlimited

 

71-85

Aa

Possesses adequate working capital. No caution needed for credit transaction. It has above average (strong) capability for payment of interest and principal sums

 

Large

 

56-70

A

Financial & operational base are regarded healthy. General unfavourable factors will not cause fatal effect. Satisfactory capability for payment of interest and principal sums

 

Fairly Large

 

41-55

Ba

Overall operation is considered normal. Capable to meet normal commitments.

 

Satisfactory

 

26-40

B

Capability to overcome financial difficulties seems comparatively below average.

 

Small

 

11-25

Ca

Adverse factors are apparent. Repayment of interest and principal sums in default or expected to be in default upon maturity

 

Limited with full security

 

<10

C

Absolute credit risk exists. Caution needed to be exercised

 

Credit not recommended

 

--

NB

New Business

--

 

This score serves as a reference to assess SC’s credit risk and to set the amount of credit to be extended. It is calculated from a composite of weighted scores obtained from each of the major sections of this report. The assessed factors and their relative weights (as indicated through %) are as follows:

 

Financial condition (40%)            Ownership background (20%)                  Payment record (10%)

Credit history (10%)                   Market trend (10%)                                Operational size (10%)

 

PRIVATE & CONFIDENTIAL : This information is provided to you at your request, you having employed MIPL for such purpose. You will use the information as aid only in determining the propriety of giving credit and generally as an aid to your business and for no other purpose. You will hold the information in strict confidence, and shall not reveal it or make it known to the subject persons, firms or corporations or to any other. MIPL does not warrant the correctness of the information as you hold it free of any liability whatsoever. You will be liable to and indemnify MIPL for any loss, damage or expense, occasioned by your breach or non observance of any one, or more of these conditions

This report is issued at your request without any risk and responsibility on the part of MIRA INFORM PRIVATE LIMITED (MIPL) or its officials.